Age associated clinical manifestations of systemic lupus erythematosus: a multivariate regression analysis
- PMID: 2348426
Age associated clinical manifestations of systemic lupus erythematosus: a multivariate regression analysis
Abstract
The influence of age on the prevalence of individual clinical manifestations of systemic lupus erythematosus (SLE) has not been adequately distinguished from racial or gender influences. Therefore, we examined variations in the clinical manifestations of SLE with age in a group of 361 patients. Multivariate regression techniques, including logistic regression and analysis of covariance, were used to identify clinical features associated with age, while controlling for important confounding factors, including race, gender, duration of followup, and treatment effects. Lymphopenia was found more frequently with increasing age, while malar rash, seizures, false-positive VDRL, thrombocytopenia (in whites), proteinuria (0.5-3.5 g/day), elevated antidouble stranded DNA antibodies, and hypocomplementemia were found less frequently. No age relationship was found for the prevalence of 16 of 24 clinical features examined, including the important disease manifestations of arthritis, serositis, psychosis, nephrotic-range proteinuria, renal failure, autoimmune hemolytic anemia, and leukopenia. The use of regression analysis allows the recognition of similarities and differences in cumulative clinical features of SLE due to age in isolation from the effects of other demographic factors.
Similar articles
-
Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus.Arch Intern Med. 1996 Jun 24;156(12):1337-44. Arch Intern Med. 1996. PMID: 8651844
-
Systemic lupus erythematosus in men: a multivariate analysis of gender differences in clinical manifestations.J Rheumatol. 1990 Feb;17(2):220-4. J Rheumatol. 1990. PMID: 2319521
-
Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual.Arthritis Rheum. 2006 Oct 15;55(5):799-806. doi: 10.1002/art.22224. Arthritis Rheum. 2006. PMID: 17013840
-
Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.J Rheumatol. 2001 Apr;28(4):766-71. J Rheumatol. 2001. PMID: 11327248
-
Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations.Rheumatology (Oxford). 2004 Mar;43(3):358-63. doi: 10.1093/rheumatology/keh048. Epub 2003 Nov 17. Rheumatology (Oxford). 2004. PMID: 14623949
Cited by
-
Systemic lupus erythematosus arising in a patient with chronic silicosis.Rheumatol Int. 1997;16(5):217-8. doi: 10.1007/BF01330299. Rheumatol Int. 1997. PMID: 9032822 No abstract available.
-
[Frequency, clinical implication and prognostic value of lymphopenia in systemic lupus erythematosus: case-control study].Pan Afr Med J. 2015 May 4;21:3. doi: 10.11604/pamj.2015.21.3.5593. eCollection 2015. Pan Afr Med J. 2015. PMID: 26401197 Free PMC article. French.
-
A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value.Clin Rheumatol. 1998;17(6):478-84. doi: 10.1007/BF01451283. Clin Rheumatol. 1998. PMID: 9890675
-
Prognosis in systemic lupus erythematosus.Springer Semin Immunopathol. 1994;16(2-3):337-55. doi: 10.1007/BF00197527. Springer Semin Immunopathol. 1994. PMID: 7716714 Review. No abstract available.
-
Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients.Ann Rheum Dis. 1994 Oct;53(10):675-80. doi: 10.1136/ard.53.10.675. Ann Rheum Dis. 1994. PMID: 7979581 Free PMC article.
MeSH terms
LinkOut - more resources
Medical